药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ephedra sinica root
Paritaprevir
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Paritaprevir.
Ephedra sinica root
Eluxadoline
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Eluxadoline.
Ephedra sinica root
Lobeglitazone
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Lobeglitazone.
Iohexol
Zinc ascorbate
The serum concentration of Zinc ascorbate can be decreased when it is combined with Copper.
Penbutolol
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Daclatasvir.
Penbutolol
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Daclatasvir.
Penbutolol
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Daclatasvir.
Penbutolol
Satralizumab
The serum concentration of Daclatasvir can be decreased when it is combined with Satralizumab.
Penbutolol
Abametapir
The serum concentration of Daclatasvir can be increased when it is combined with Abametapir.
Penbutolol
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Daclatasvir.
Penbutolol
Ozanimod
Daclatasvir may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Penbutolol
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Daclatasvir.
Penbutolol
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Daclatasvir.
Penbutolol
Cenobamate
The serum concentration of Daclatasvir can be decreased when it is combined with Cenobamate.
Penbutolol
Lefamulin
Daclatasvir may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Penbutolol
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Daclatasvir.
Penbutolol
Acetyldigoxin
Daclatasvir may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Penbutolol
Metildigoxin
Daclatasvir may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Penbutolol
Emapalumab
The metabolism of Daclatasvir can be increased when combined with Emapalumab.
Penbutolol
Siltuximab
The metabolism of Daclatasvir can be increased when combined with Siltuximab.